The metabolic adverse effects of topiramate have been well documented in the pediatric population, [4,5] but case reports in the adult population are limited. [6,7,8,9,10,11] Published reports that ...

Topiramate (Topamax) 25 mg once daily, titrated to 300 mg/day in two divided doses for 14 weeks, was evaluated in a placebo-controlled randomized trial in 371 patients aged 18-65 years with alcohol ...

The aim of this study was to evaluate the efficacy, tolerability, and adherence to treatment with topiramate in patients with episodic and chronic migraine who were undergoing treatment at a private ...